Survival Benefits of Chemotherapy and Radiotherapy in Head and Neck Cancer
Author Information
Author(s): W. Budach, T. Hehr, V. Budach, C. Belka, K. Dietz
Primary Institution: University Hospital Düsseldorf, Germany
Hypothesis
Does the addition of chemotherapy to radiotherapy improve overall survival in patients with locally advanced squamous cell carcinoma of the head and neck?
Conclusion
Combining radiation therapy with chemotherapy significantly improves survival in patients with head and neck cancer, especially with hyperfractionated radiation.
Supporting Evidence
- Overall survival benefit of 12.0 months was observed for the addition of simultaneous chemotherapy.
- 5-fluorouracil as sole chemotherapy revealed an increase in overall survival time of 24.0 months.
- HFRT showed a survival benefit of 14.2 months compared to CFRT.
Takeaway
Giving chemotherapy along with radiation helps people with head and neck cancer live longer. Using a special type of radiation called hyperfractionation is especially good.
Methodology
The study analyzed randomized trials comparing different radiation and chemotherapy regimens for head and neck cancer published between 1975 and 2003.
Potential Biases
Potential bias from excluding studies with older treatment regimens that may have affected overall survival estimates.
Limitations
The study excluded trials using outdated chemotherapy drugs and those with subcurative radiation doses.
Participant Demographics
Predominantly male patients (median percentage 85%) with locally advanced head and neck cancer.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI: 7.7 to 16.9 months
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website